期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸)in the treatment of premenstrual syndrome(liver depression,spleen deficiency,and blood-heat syndrome):a multi-center,randomized,placebo-controlled trial
1
作者 LI Xiyu YANG Yanhong +8 位作者 SUN Jian NIE Quanfang LIU Lifen LI Guifen YU Junping ZHANG Zhuangjin XU Yi ZOU Ting SHI Yun() 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第2期373-380,共8页
OBJECTIVE:To investigate the effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸,JXP)in the treatment of symptoms associated with premenstrual syndrome(PMS).METHODS:A total of 144 regularly menstruating women w... OBJECTIVE:To investigate the effectiveness and safety of Jiawei Xiaoyao pill(加味逍遥丸,JXP)in the treatment of symptoms associated with premenstrual syndrome(PMS).METHODS:A total of 144 regularly menstruating women with PMS were recruited at 8 sites in China from August 2017 to December 2018,and randomized to receive either a JXP or a matching placebo(12 g/d,6 g twice a day)for 3 menstrual cycles.The primary indicator was the reduced Daily Record of Severity of Problems(DRSP)scores in the luteal phase after 3 months of treatment.The safety outcomes included clinical adverse events(AEs),adverse reactions(ARs),changes in vital signs,and laboratory tests.RESULTS:JXP surpassed the placebo in reducing DRSP scores(psychological/somatic dysfunction)in the luteal phase over 3 menstrual cycles of treatment(PFAS=0.002,PPPS=0.001).Additionally,there were no significant differences in the incidence of AEs,severe AEs,withdrawal due to AEs and ARs between the two groups(all P>0.05),and no clinically significant adverse medical events related to the test drug observed.CONCLUSIONS:JXP was superior to the placebo in relieving the symptoms associated with PMS,which signified that JXP may be effective,safe,and welltolerated as an alternative therapy. 展开更多
关键词 premenstrual syndrome randomized controlled trial double-blind method Jiawei xiaoyao pill
原文传递
Effects and Potential Mechanisms of Danzhi Xiaoyao Pill(丹栀逍遥丸) on Proliferation of MCF-7 Human Breast Cancer Cells in vitro 被引量:1
2
作者 廖晖 Linda K Banbury David N Leach 《Chinese Journal of Integrative Medicine》 SCIE CAS 2008年第2期128-131,共4页
Objective: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (丹栀逍遥丸, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms. Methods: AT... Objective: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (丹栀逍遥丸, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms. Methods: ATP-Lite assay was performed to test the proliferation of the MCF-7 breast cancer cell line; and antioxidant activity was measured by the oxygen radical absorbance capacity (ORAC). The effects of DXP on nitric oxide (NO) production were tested by lipopolysaccharide (LPS)- stimulated RAW 264.7 murine macrophages using the Griess reaction. Results: The 50% EtOH DXP extracts displayed a cytotoxic response on MCF-7 cells at 0.10, 0.25 and 0.50 mg/mL dosedependently with the proliferation inhibited by more than 85%. The ORAC value of the DXP was 820μ moL Trolox equivalent/g, about 40% of the vitamin C value. DXP extracts had significant inhibitory effect on NO production at the concentration from 0.0625 mg/mL to 0.5 mg/mL (P〈0.05, P〈0.01). Conclusion: The extracts of DXP could significantly inhibit the proliferation of MCF-7 cells, with the effect possibly related to its antioxidant activity and the inhibition of NO production. 展开更多
关键词 Danzhi xiaoyao Pill breast cancer MCF-7 cells antioxidant activity oxygen radical absorbance capacity nitric oxide
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部